Additional file 2: of Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children â a EuroCoord-CHAIN-EPPICC joint project
- Nicole Ngo-Giang-Huong (147034)
- Linda Wittkop (3425675)
- Ali Judd (3425666)
- Peter Reiss (4933)
- Tessa Goetghebuer (784489)
- Dan Duiculescu (3425657)
- Antoni Noguera-Julian (577116)
- Magdalena Marczynska (3425684)
- Carlo Giacquinto (3425678)
- Luminita Ene (3425660)
- Jose Ramos (156629)
- Cristina Cellerai (178909)
- Thomas Klimkait (178911)
- Benedicte Brichard (3425669)
- Niels Valerius (3425681)
- Caroline Sabin (252688)
- Ramon Teira (3425672)
- Niels Obel (135891)
- Christoph Stephan (283267)
- StĂŠphane de Wit (3425729)
- Claire Thorne (291398)
- Diana Gibb (324183)
- Christine Schwimmer (3425654)
- Maria Campbell (144606)
- Deenan Pillay (7888)
- Marc Lallemant (96226)
Publication date
November 2016
DOIAbstract
Crude Hazard Ratios (cHR) and adjusted Hazard Ratios (aHR) for the association between PDR and resistant group versus no PDR/susceptible group from Cox proportional Hazards models stratified by initial cART regimen. HR in the overall group are also presented in more details in Table 3 of the article. All models were adjusted for sex, age, pre-treatment viral load (log10 transformed) and CD4 count, subtype, region of origin, year of treatment start, previous AIDS diagnosis and HIV transmission risk group. (DOCX 46 kb
Add to ORKG